Palisade Bio (PALI) Return on Sales Growth (1y) (2012 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 4.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.00 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 6,311.00 |
| Jun 30, 2023 | 2,850.00 |
| Mar 31, 2023 | 5,920.00 |
| Dec 31, 2020 | -524.00 |
| Sep 30, 2020 | 110.00 |
| Jun 30, 2020 | -495.00 |
| Mar 31, 2020 | 643.00 |
| Dec 31, 2019 | -136.00 |
| Sep 30, 2019 | -18.00 |
| Jun 30, 2019 | -234.00 |
| Mar 31, 2019 | -39.00 |
| Dec 31, 2018 | -705.00 |
| Sep 30, 2018 | 202.00 |
| Jun 30, 2018 | 1,680.00 |
| Mar 31, 2018 | 807.00 |
| Dec 31, 2017 | 657.00 |
| Sep 30, 2017 | 1,028.00 |
| Jun 30, 2017 | -31.00 |
| Mar 31, 2017 | 904.00 |
| Dec 31, 2016 | 1,244.00 |
| Sep 30, 2016 | 199.00 |
| Jun 30, 2016 | 518.00 |
| Mar 31, 2016 | -911.00 |
| Dec 31, 2015 | -826.00 |
| Sep 30, 2015 | -1,364.00 |
| Jun 30, 2015 | -1,397.00 |
| Mar 31, 2015 | -392.00 |
| Dec 31, 2014 | 195.00 |
| Sep 30, 2014 | 735.00 |
| Jun 30, 2014 | 685.00 |
| Mar 31, 2014 | -1,312.00 |
| Dec 31, 2013 | -193.00 |
| Sep 30, 2013 | -1,611.00 |
| Jun 30, 2013 | -1,433.00 |
| Mar 31, 2013 | -13.00 |
| Dec 31, 2012 | -1,077.00 |
| Sep 30, 2012 | 16.00 |